Pharma-Bio Serv (OTCMKTS:PBSV) Stock Price Up 2.7% – Time to Buy?

Pharma-Bio Serv Inc. (OTCMKTS:PBSV)’s stock price shot up 2.7% on Monday . The company traded as high as $0.58 and last traded at $0.58. 2,500 shares changed hands during trading, an increase of 1,201% from the average session volume of 192 shares. The stock had previously closed at $0.5650.

Pharma-Bio Serv Stock Up 2.7%

The firm’s fifty day moving average price is $0.55 and its 200-day moving average price is $0.54.

Pharma-Bio Serv (OTCMKTS:PBSV) last posted its quarterly earnings results on Monday, June 15th. The company reported $0.01 EPS for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02). The firm had revenue of $2.70 billion for the quarter, compared to the consensus estimate of $2.70 million. Pharma-Bio Serv had a net margin of 0.68% and a return on equity of 0.56%. On average, research analysts forecast that Pharma-Bio Serv Inc. will post 0.07 EPS for the current fiscal year.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc was founded in 1993 and is headquartered in Dorado, Puerto Rico.